In women with epilepsy, use of valproate in the second half of pregnancy was linked to autism in offspring

被引:0
|
作者
Singh, Balwinder [1 ]
机构
[1] Mayo Clin, Rochester, MN 55905 USA
关键词
D O I
10.7326/ANNALS-24-00855-JC
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Source Citation Hernandez-Diaz S, Straub L, Bateman BT, et al. Risk of autism after prenatal topiramate, valproate, or lamotrigine exposure. N Engl J Med. 2024;390:1069-1079. 38507750 Clinical Impact Ratings Mental Health: GIM/FP/GP: Neurology:
引用
收藏
页码:JC82 / JC82
页数:1
相关论文
共 50 条
  • [41] Low maternal folic acid in women with epilepsy during pregnancy is linked to autistic traits in the child at 3 years of age
    Bjork, M. H.
    Veiby, G.
    Spigset, O.
    Riedel, B.
    Kolstad, E.
    Daltveit, A. K.
    Gilhus, N. E.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 918 - 918
  • [42] Effects of Maternal Epilepsy and Antiepileptic Drug Use during Pregnancy on Perinatal Health in Offspring: Nationwide, Retrospective Cohort Study in Finland
    Artama, Miia
    Gissler, Mika
    Malm, Heli
    Ritvanen, Annukka
    [J]. DRUG SAFETY, 2013, 36 (05) : 359 - 369
  • [43] Effects of Maternal Epilepsy and Antiepileptic Drug Use during Pregnancy on Perinatal Health in Offspring: Nationwide, Retrospective Cohort Study in Finland
    Miia Artama
    Mika Gissler
    Heli Malm
    Annukka Ritvanen
    [J]. Drug Safety, 2013, 36 : 359 - 369
  • [44] Use of valproate in pregnancy and in women of childbearing age between 2014 and 2018 in Switzerland: a retrospective analysis of Swiss healthcare claims data
    Julia, Spoendlin
    Eva, Blozik
    Sereina, Graber M.
    Marlene, Rauch
    Carole, Marxer A.
    Stephan, Ruegg
    Christoph, Meier
    Ursula, Winterfeld
    Alice, Panchaud
    [J]. SWISS MEDICAL WEEKLY, 2021, 151
  • [45] Materno-fetal outcome with PlGF above or below cutoff during second half of pregnancy in high-risk women
    Balyan, Kirti
    Humtso, Benchumi Y.
    Meena, Bhawana
    Sapna, Surbhi
    Rana, Anjali
    Kumar, Manisha
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2024, 165 (01) : 211 - 219
  • [46] The impact and challenges of the 2018 MHRA statement on the use of sodium valproate in women of childbearing age during the first year of implementation, in a UK epilepsy centre
    Davies, Philippa
    Reuber, Markus
    Grunewald, Richard
    Howell, Stephen
    Dickson, Jon
    Dennis, Gary
    Shanmugarajah, Priya
    Tsironis, Theocharis
    Brockington, Alice
    [J]. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2020, 79 : 8 - 13
  • [47] Expert opinion: use of valproate in girls and women of childbearing potential with epilepsy: recommendations and alternatives based on a review of the literature and clinical experience—a European perspective
    Manuel Toledo
    Barbara Mostacci
    Magdalena Bosak
    Joanna Jedrzejzak
    Rhys H. Thomas
    Javier Salas-Puig
    Arnaud Biraben
    Bettina Schmitz
    [J]. Journal of Neurology, 2021, 268 : 2735 - 2748
  • [48] International League Against Epilepsy/European Academy of Neurology Recommendations on the Use of Valproate in Girls and Women of Childbearing Age - How do They Work in Practice
    Bosak, M.
    Turaj, W.
    [J]. EPILEPSIA, 2018, 59 : S323 - S323
  • [49] The safety of misoprostol alone use for second-trimester termination of pregnancy in women with previous caesarean deliveries
    Erturk, Anil
    Karapinar, Bayram Tunahan
    Tasgoz, Fatma Nurgul
    Dundar, Betul
    Kender Erturk, Nergis
    [J]. EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2022, 27 (06): : 473 - 477
  • [50] The use of vaginal misoprostol for second-trimester pregnancy termination in women with previous single cesarean section
    Daponte, Alexandros
    Nzewenga, Guy
    Dimopoulos, Konstantinos D.
    Guidozzi, Franco
    [J]. CONTRACEPTION, 2006, 74 (04) : 324 - 327